57.60
-1.60
(-2.70%)
At close: 1:30:14 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,050,973.00
810,917.00
741,066.00
413,483.00
447,862.00
Cost of Revenue
511,797.00
411,018.00
351,196.00
166,125.00
162,670.00
Gross Profit
539,176.00
399,899.00
389,870.00
247,358.00
285,192.00
Operating Expense
379,540.00
338,203.00
320,806.00
191,843.00
210,991.00
Operating Income
159,636.00
61,696.00
69,064.00
55,515.00
74,201.00
Net Non Operating Interest Income Expense
4,324.00
5,912.00
2,634.00
2,019.00
2,211.00
Pretax Income
168,619.00
76,091.00
81,241.00
61,549.00
77,232.00
Tax Provision
27,663.00
11,113.00
15,098.00
14,441.00
15,662.00
Net Income Common Stockholders
119,679.00
61,989.00
61,890.00
47,108.00
61,570.00
Diluted NI Available to Com Stockholders
119,679.00
61,989.00
61,890.00
47,108.00
61,570.00
Basic EPS
3.12
1.61
1.61
1.23
1.60
Diluted EPS
3.11
1.61
1.61
1.23
1.60
Basic Average Shares
38,281.79
38,398.00
38,398.00
38,299.19
38,398.00
Diluted Average Shares
38,424.65
38,434.00
38,452.00
38,299.19
38,430.00
Total Expenses
891,337.00
749,221.00
672,002.00
357,968.00
373,661.00
Net Income from Continuing & Discontinued Operation
119,679.00
61,989.00
61,890.00
47,108.00
61,570.00
Normalized Income
121,032.39
60,337.46
64,364.23
47,031.46
61,487.89
Interest Income
4,748.00
6,600.00
3,333.00
2,099.00
2,238.00
Interest Expense
424.00
688.00
699.00
80.00
27.00
Net Interest Income
4,324.00
5,912.00
2,634.00
2,019.00
2,211.00
EBIT
169,043.00
76,779.00
81,940.00
61,629.00
77,259.00
EBITDA
196,550.00
99,350.00
103,467.00
71,414.00
86,908.00
Reconciled Cost of Revenue
511,797.00
411,018.00
351,196.00
166,125.00
162,670.00
Reconciled Depreciation
27,507.00
22,571.00
21,527.00
9,785.00
9,649.00
Net Income from Continuing Operation Net Minority Interest
119,679.00
61,989.00
61,890.00
47,108.00
61,570.00
Total Unusual Items Excluding Goodwill
-1,619.00
1,934.00
-3,039.00
100.00
103.00
Total Unusual Items
-1,619.00
1,934.00
-3,039.00
100.00
103.00
Normalized EBITDA
198,169.00
97,416.00
106,506.00
71,314.00
86,805.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-265.61
282.46
-564.77
23.46
20.89
12/31/2020 - 4/30/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4105.TWO TTY Biopharm Company Limited
74.90
-0.13%
4120.TWO Orient EuroPharma Co., Ltd.
47.00
-0.63%
1731.TW Maywufa Company Ltd.
22.60
+0.44%
6496.TWO Excelsior Biopharma Inc.
31.25
-2.34%
6576.TWO Foresee Pharmaceuticals Co., Ltd.
76.30
0.00%
4747.TWO Johnson Chemical Pharmaceutical Works Co., Ltd.
71.50
-1.65%
4127.TWO Tien Liang BioTech Co., Ltd.
40.00
-0.50%
1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
60.80
-1.14%
4108.TW PhytoHealth Corporation
16.10
-1.23%
1799.TWO Easywell Biomedicals, Inc.
61.00
-3.02%